ReWind Therapeutics (SA)
Active
VAT
BE 0682.626.216
Address
Gaston Geenslaan 3
3001
Leuven
Established
29-09-2017
Principal activity
Research and experimental development on biotechnology
Crisis resilience of ReWind Therapeutics
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of ReWind Therapeutics
2022
|
2021
|
2020
|
2019
|
||||
|---|---|---|---|---|---|---|---|
| Profit/Loss | -€4,511,572 | -54% |
-€2,938,722 | 17% |
-€3,532,917 | -57% |
-€2,256,012 |
| Equity | €1,631,738 | -73% |
€6,143,310 | 4% |
€5,885,860 | -38% |
€9,418,776 |
| Gross margin | -€294,468 | -143% |
€678,706 | 328% |
-€297,513 | -195% |
€312,395 |
| Employees | 7,7 FTE | 28% |
6 FTE | 114% |
2,8 FTE | 180% |
1 FTE |
Publications in the Belgian Official Journal for ReWind Therapeutics
Frequently asked questions
What is the VAT number of ReWind Therapeutics?
The VAT number of ReWind Therapeutics is BE0682626216.
When was ReWind Therapeutics founded?
ReWind Therapeutics was founded on 29-09-2017.
What is the address of ReWind Therapeutics?
The current registered office of ReWind Therapeutics is located at Gaston Geenslaan 3, 3001 Leuven.
When was the last time ReWind Therapeutics filed their annual financial statements?
The most recent financial statements of ReWind Therapeutics were filed on 01-06-2023. You can view them here.
How many employees does ReWind Therapeutics have?
There are 7,7 FTEs working at ReWind Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of ReWind Therapeutics?
At the time of its most recent financial statements, ReWind Therapeutics did not publish any turnover figures. ReWind Therapeutics reported a gross margin of -€294,468.16.
